NRGENE TECHNOLOGIES LTD (IL:NRGN)
TASE:NRGN
Want to see IL:NRGN full AI Analyst Report?
NRGN Stock Chart & Stats
204.80
0.03(0.96%)
At close: 4:00 PM EST
204.80
0.03(0.96%)
Day’s Range― - ―
52-Week Range190.80 - 390.00
Previous CloseN/A
Volume1.26K
Average Volume (3M)27.56K
Market Cap
₪31.19M
Enterprise Value7.25M
Total Cash (Recent Filing)₪5.30M
Total Debt (Recent Filing)₪181.00K
Price to Earnings (P/E)―
Beta0.58
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding13,327,785
10 Day Avg. Volume57,803
30 Day Avg. Volume27,561
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)1.94
Price to Sales (P/S)2.64
P/FCF Ratio116.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue ReboundA +251% top-line rebound in 2025 indicates a material reversal of prior decline and suggests product-market traction or renewed commercial execution. Over 2–6 months this supports sustainable revenue scaling, better capacity utilization and a clearer path to leverage fixed costs into improved operating results.
Gross Margin ExpansionA jump to ~60.6% gross margin reflects substantially improved unit economics or higher-quality revenue mix. Higher gross margins create durable operating leverage, improve cash conversion potential, and provide structural capacity to invest in R&D or go-to-market while insulating profits from modest pricing or cost pressure.
Improved Cash Generation & Low LeverageTransition to positive operating cash flow and a small positive FCF, combined with very low debt-to-equity, materially strengthen financial flexibility. This durable improvement reduces near-term financing needs, allows self-funding of selective investments, and lowers solvency risk versus peers reliant on external capital.
Bears Say
Persistent LossesVery large negative net and EBIT margins show the company has not yet converted revenue gains into sustainable profitability. Over months this limits retained earnings, constrains reinvestment capacity, and keeps the firm dependent on continued margin recovery or external funding to reach true earnings durability.
Fragile Free Cash FlowAlthough FCF turned slightly positive, its small scale and major year-over-year decline indicate cash generation is not yet stable. This fragility undermines the firm's ability to self-fund growth, raises the probability of recurring financing needs, and makes capital allocation decisions riskier for durable expansion.
Negative Returns & Equity VolatilityDeeply negative ROE and historical equity volatility (including past negative equity) signal persistent capital destruction. Over the medium term this can impair investor confidence, raise cost of capital, and constrain strategic options if losses recur, limiting the durability of operational improvements.
NRGN FAQ
What was NRGENE TECHNOLOGIES LTD’s price range in the past 12 months?
NRGENE TECHNOLOGIES LTD lowest stock price was 190.80 and its highest was 390.00 in the past 12 months.
What is NRGENE TECHNOLOGIES LTD’s market cap?
NRGENE TECHNOLOGIES LTD’s market cap is ₪31.19M.
When is NRGENE TECHNOLOGIES LTD’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NRGENE TECHNOLOGIES LTD’s earnings last quarter?
Currently, no data Available
Is NRGENE TECHNOLOGIES LTD overvalued?
According to Wall Street analysts NRGENE TECHNOLOGIES LTD’s price is currently Overvalued.
Does NRGENE TECHNOLOGIES LTD pay dividends?
NRGENE TECHNOLOGIES LTD does not currently pay dividends.
What is NRGENE TECHNOLOGIES LTD’s EPS estimate?
NRGENE TECHNOLOGIES LTD’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NRGENE TECHNOLOGIES LTD have?
NRGENE TECHNOLOGIES LTD has 13,327,785 shares outstanding.
What happened to NRGENE TECHNOLOGIES LTD’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NRGENE TECHNOLOGIES LTD?
Currently, no hedge funds are holding shares in IL:NRGN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NRGENE TECHNOLOGIES LTD
NRGene Technologies Ltd is an AI-powered genomics firm that designs sophisticated computational tools and advanced algorithms, serving clients globally across North America, Europe, the Middle East, Africa, and Asia Pacific. The company provides specialized software applications and complete, ready-to-use solutions for various sectors, including agricultural breeding, food technology, academia, research institutions, and agribiotech enterprises. Additionally, NRGene develops custom genetic panels tailored for a broad range of plants, from staple crops like wheat, canola, corn, soybeans, and maize to cannabis. Established in 2009, its headquarters are located in Ness Ziona, Israel.